Zimbabwe

previous Print

HIV/AIDS Statistics for Zimbabwe

Total population in thousands (2007): 13,349*
Number of people living with HIV (2007): 1,300,000*
Adults aged 15 to 49 prevalence rate (2007): 15.3*
Prevalence male aged 15 to 24 prevalence rate (2007): 2.9*
Adults aged 15 and up living with HIV (2007): 1,200,000*
Women aged 15 and up living with HIV (2007): 680,000*
Estimated number of deaths due to AIDS (2007): 140,000*
Estimated antiretroviral therapy coverage (Dec 2007): 17%†
Estimated number of pregnant women living with HIV (2007): 52,000†


Ongoing biomedical HIV prevention research trials in Zimbabwe
PrEP PrEP & Microbicides Partner Treatment

Pre-Exposure Prophylaxis

Trial: Study to assess the role of Truvada® in preventing HIV acquisition in women [FEM-PrEP]
Phase: III
Product Being Tested: Daily oral TDF/FTC (Truvada®)
Sponsor, funder, developer, collaborator:Family Health International, United States Agency for International Development, Bill and Melinda Gates Foundation, Setshaba Research Centre, University of Cape Town
Total participants: 3,900
Countries: Kenya, South Africa, Tanzania, Zimbabwe
Trial sites in South Africa: Gauteng, Western Cape
Results expected:2013
For more information: http://clinicaltrials.gov/ct2/show/NCT00625404
Back to Top ↑

PrEP & Microbicides

Trial: Vaginal and Oral Interventions to Control the Epidemic [VOICE (MTN-003)]
Phase: IIb
Product Being Tested: Daily oral TDF, daily oral TDF/FTC, daily topical tenofovir gel
Sponsor, funder, developer, collaborator: Microbicide Trials Network, Division of AIDS/National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Mental Health; Gilead, CONRAD
Total participants: up to 5,000
Countries: Malawi, South Africa, Uganda, Zimbabwe
Trial sites in Zimbabwe: Harare
Results expected: 2013
For more information: http://www.mtnstopshiv.org/news/studies/mtn003, http://www.mtnstopshiv.org/node/70
Back to Top ↑

Partner Treatment


Trial: Evaluation of the effectiveness of two antiretroviral treatment strategies to prevent HIV transmission in HIV-serodiscordant couples [HPTN 052]
Phase: III
Product Being Tested: Highly active antiretroviral therapy for HIV prevention
Sponsor, funder, developer, collaborator: The HIV Prevention Trials Network
Total participants: 1,750 couples
Countries: Botswana, Brazil, India, Kenya, Malawi, South Africa, Thailand, Zimbabwe
Trial sites in Zimbabwe: Harare
Results expected: n/a
For more information: http://www.hptn.org/research_studies/hptn052.asp
Back to Top ↑

*WHO, UNAIDS, and UNICEF. Epidemiological Fact Sheet on HIV and AIDS: Core data on epidemiological and response Zimbabwe 2008 Update. 2008.
For more information: http://www.who.int/globalatlas/predefinedReports/EFS2008/full/EFS2008_ZW.pdf
† WHO, UNAIDS, and UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: Progress Report. 2008.
For more information: http://www.who.int/hiv/pub/towards_universal_access_report_2008.pdf